LACOSAMIDE

LACOSAMIDE Struktur
175481-36-4
CAS-Nr.
175481-36-4
Englisch Name:
LACOSAMIDE
Synonyma:
ViMpat;Erlosamide;Lacosamide API;(R)-2-Acetamido-N-benzyl-3-methoxypropanamide;(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide;SPM 927;LACOSAMIDE;ADD 243037;Lacoxamide;Lacosamine
CBNumber:
CB41011740
Summenformel:
C13H18N2O3
Molgewicht:
250.29
MOL-Datei:
175481-36-4.mol

LACOSAMIDE Eigenschaften

Schmelzpunkt:
141-143?C
alpha 
D23 +16.0° (c = 1 in CH3OH)
Siedepunkt:
536.4±50.0 °C(Predicted)
Dichte
1.120±0.06 g/cm3(Predicted)
Flammpunkt:
2℃
storage temp. 
Refrigerator
Löslichkeit
DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml; PBS (pH 7.2): 2 mg/ml
Aggregatzustand
A crystalline solid
pka
14.19±0.46(Predicted)
InChIKey
VPPJLAIAVCUEMN-GFCCVEGCSA-N
CAS Datenbank
175481-36-4
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher F,Xn
R-Sätze: 11-20/21/22-36
S-Sätze: 16-26-36/37
RIDADR  UN 1648 3 / PGII
WGK Germany  2
HS Code  2924296000
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H225 Flüssigkeit und Dampf leicht entzündbar. Entzündbare Flüssigkeiten Kategorie 2 Achtung GHS hazard pictogramssrc="/GHS02.jpg" width="20" height="20" /> P210,P233, P240, P241, P242, P243,P280, P303+ P361+P353, P370+P378,P403+P235, P501
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
Sicherheit
P210 Von Hitze, heißen Oberflächen, Funken, offenen Flammen und anderen Zündquellenarten fernhalten. Nicht rauchen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

LACOSAMIDE Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Although epilepsy is a neurological disorder with varying etiology and severity, the common feature is unprovoked, recurring seizures. Whether classified as generalized, involving both cerebral hemispheres, or partial with only localized portions of brain participation at onset, effective treatment relies on accurate assessment of syndrome type to optimally decrease the frequency, duration, and severity of seizures. The latest weapon against partial onset epilepsy is lacosamide, formerly known as harkoseride and erlosamide. The data also indicate that lacosamide binds to collapsing response mediator protein 2 (CRMP2); CRMP2 is involved in neuronal differentiation, control of axonal outgrowth, and possibly epileptogenesis. Furthermore, lacosamide is heralded as having a dual mode of action as it has also displayed efficacy against diabetic neuropathy, possibly as a result of stabilization of neuronal hyperexcitability. Currently,lacosamide is approved as adjunctive treatment of partial onset seizures in patients 17 years or older and is in development as a monotherapy for epilepsy and for neuropathic pain.

Chemische Eigenschaften

White to Off-White Solid

Verwenden

A potent anticonvulsant.

LACOSAMIDE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


LACOSAMIDE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 480)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 5993 58
Changzhou Rokechem Technology Co., Ltd.
18758118018
sales001@rokechem.com China 255 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 11013 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Nanjing Gold Pharmaceutical Technology Co. Ltd.
025-84209270 15906146951
CHINA 115 55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21695 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9348 55
Shanghai Yingrui Biopharma Co., Ltd.
+86-21-33585366 - 03@
sales03@shyrchem.com CHINA 738 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58

175481-36-4()Verwandte Suche:


  • LACOSAMIDE
  • (2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide
  • ADD 243037
  • Harkoseride
  • SPM 927
  • (2R)-N-benzyl-2-acetaMido-3-MethoxypropanaMide
  • LacosaMide (1.0Mg/ML in Acetonitrile)
  • (R)-2-Acetamido-N-benzyl-3-methoxypropionamide
  • Lacosamide solution
  • Lacosamide-d3 (Acetyl-d3)
  • (2R)-2-ACETAMIDO-3-METHOXY-N-(PHENYLMETHYL)PROPANAMIDE
  • (R)-2-acetamido-N-benzyl-3-_x001f_methoxypropionamide
  • Lacosamide CRS
  • Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-
  • Can sand meters
  • LACOSAMIDE USP/EP/BP
  • 2R-(acetylamino)-3-methoxy-N-(phenylmethyl)-propanamide
  • LACOSAMIDE (Y0001982)
  • LacosamideQ: What is Lacosamide Q: What is the CAS Number of Lacosamide Q: What is the storage condition of Lacosamide Q: What are the applications of Lacosamide
  • Lacosamide for system suitability (Y0001973)
  • Lacosamide for system suitability CRS (Y0001973)
  • (2R)-2-acetamido-N-benzyl-3-methoxy-propanamide
  • Erlosamide
  • (R)-2-Acetamido-N-benzyl-3-methoxypropanamide
  • ViMpat
  • Lacosamide API
  • Propanoicacid,7-methyl-,tetradecylester
  • Lacoxamide
  • Lacosamide solution iMpurity
  • Lacosamide (2R)-2-(Acetylamino)-3-methoxy-N- (phenylmethyl)propanamide
  • Lacosamine
  • Lecosamide Reference Standard
  • 175481-36-4
  • Inhibitors
  • Other APIs
  • API
  • Pharmaceutical raw material
  • Amino Acids 13C, 2H, 15N
  • Amino Acids & Derivatives
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • 175481-36-4
Copyright 2019 © ChemicalBook. All rights reserved